{"id":"W4387811450","doi":"10.1016/j.annonc.2023.09.1919","title":"740MO Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC): Analysis of progression free survival (PFS) and overall survival (OS) outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Seagen; AstraZeneca","keywords":"Medicine; Internal medicine; Microsatellite instability; Oncology; Carboplatin; Endometrial cancer; Progression-free survival; Population; Cancer; Chemotherapy; Cisplatin; Gene; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001321517,0.0007521154,0.001591984,0.0002107237,0.0002317076,0.0007223843,0.0005011793,0.0005346814,0.002169137],"category_scores_gemma":[0.0007929667,0.0002719704,0.001620571,0.0003157441,0.0005767637,0.0005654584,0.0003633009,0.001736091,0.0004085534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006052796,"about_ca_system_score_gemma":0.0007048589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001311661,"about_ca_topic_score_gemma":0.005374016,"domain_scores_codex":[0.9995593,0.0002616273,0.00001753201,0.00006085398,0.00003007975,0.00007067018],"domain_scores_gemma":[0.9996779,0.00007960646,0.00007614981,0.00003597697,0.00001435351,0.0001160425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8670833,0.003212038,0.01735896,0.001245372,0.005381178,0.00009089016,0.0001076898,0.00231332,0.00577632,0.0004969102,0.003790282,0.09314378],"study_design_scores_gemma":[0.6529916,0.2010089,0.1169041,0.0003441095,0.01000705,0.0004670898,0.0002017618,0.003826099,0.00219351,0.001678502,0.01030279,0.00007442696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904112,0.006190494,0.0001315191,0.0004379314,0.0001256432,0.0001963407,0.0007228829,0.00003326078,0.001750753],"genre_scores_gemma":[0.9911695,0.003158043,0.0006374013,0.0008207781,0.0001716243,0.000272051,0.001955846,0.00001624347,0.001798465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002169137,"threshold_uncertainty_score":0.007256448,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1521297895245249,"score_gpt":0.4537762290788031,"score_spread":0.3016464395542782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}